Head-to-head · WeighScore
AVARA Rx vs RxSpan MD
By GLP-1 ScorecardUpdated
Score comparison
RxSpan MD has the higher recorded score — 84.3/100 to 62.8/100.
RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.
Before you choose
RxSpan MD does not publish a semaglutide price, so its RxSpan MD review sets out what it does disclose, while the AVARA Rx review explains the conditions attached to AVARA Rx's figure. The semaglutide cost page compares published rates across the field. Ask RxSpan MD for a written total before treating either one as the cheaper choice.
If neither one fits, AVARA Rx vs Synergy Rx and Balanced Hormone Health vs RxSpan MD compare each of them with another graded program, and the list of alternatives to AVARA Rx ranks the programs closest to AVARA Rx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | AVARA Rx | RxSpan MD |
|---|---|---|
| WeighScore | 62.8/100 | 84.3/100 |
| Grade | C | B |
| Site position | #285 | #4 |
| Semaglutide | Personalized "GLP-1" (drug not named) starting at $229 | Current compounded quote unconfirmed |
| Tirzepatide | Personalized "GLP-1/GIP" (drug not named) starting at $279 | Current compounded quote unconfirmed |
| Coverage | All 50 states | Confirm treatment availability during intake |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Names its pharmacy partner (DiRx Health, Ft Lauderdale FL) — buyers can independently verify its licensure
- Names its clinical network (Beluga Health) — you can research the platform handling your prescriptions
- All 50 states explicitly listed on the FAQ — uncommon vs peers that just say 'nationwide'
- Patient-friendly refunds — full refund if a provider disqualifies you, partial if a weaker dose is prescribed
- LegitScript verification badge displayed; pharmacy claims NABP-accredited facilities
What to consider
- Operating legal entity not disclosed — only a Sheridan, WY registered-agent-style address surfaced
- Dose pricing not itemized — only 'starting at $229' for GLP-1 and 'starting at $279' for GLP-1/GIP, without naming either drug
- LegitScript certification number not shown — badge only, so no direct lookup
- No named medical director (Beluga Health is the network, not a named MD)
- Lab work requirements not specified, and consultation fee not broken out from medication cost
Site position #4 · B
Strengths
- Current public catalog lists Ozempic, Wegovy, Mounjaro and Zepbound
- Public terms describe independent healthcare providers
- Homepage describes messaging and care-team appointments
What to consider
- Homepage advertises compounded plans that the current catalog did not substantiate
- Current oral GLP-1 availability is unconfirmed
- Prior compounded prices are not a current quote; selected dose, supply, pharmacy and fee inclusions need confirmation
- Public terms do not establish unused prepaid-treatment refund amounts
Featured provider
RxSpan MD
RxSpan MD scores 84.3/100 (B). RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.